Shenzhen Vital New Material Future Growth
Future criteria checks 4/6
Shenzhen Vital New Material is forecast to grow earnings and revenue by 28.3% and 17.7% per annum respectively. EPS is expected to grow by 28.4% per annum. Return on equity is forecast to be 12.9% in 3 years.
Key information
28.3%
Earnings growth rate
28.4%
EPS growth rate
| Electronic earnings growth | 32.3% |
| Revenue growth rate | 17.7% |
| Future return on equity | 12.9% |
| Analyst coverage | Low |
| Last updated | 29 Apr 2024 |
Recent future growth updates
No updates
Recent updates
We Think That There Are Some Issues For Shenzhen Vital New Material (SZSE:301319) Beyond Its Promising Earnings
Nov 04
Shenzhen Vital New Material's (SZSE:301319) Dividend Will Be Increased To CN¥1.40
May 26Shenzhen Vital New Material's (SZSE:301319) Profits Appear To Have Quality Issues
May 02Shenzhen Vital New Material (SZSE:301319) Could Be Struggling To Allocate Capital
Feb 26Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,652 | 197 | N/A | 95 | 1 |
| 12/31/2025 | 1,412 | 169 | N/A | 101 | 1 |
| 12/31/2024 | 1,187 | 127 | N/A | 106 | 1 |
| 9/30/2024 | 1,109 | 98 | -1 | 38 | N/A |
| 6/30/2024 | 1,052 | 100 | 25 | 41 | N/A |
| 3/31/2024 | 987 | 97 | 50 | 56 | N/A |
| 12/31/2023 | 964 | 102 | 52 | 57 | N/A |
| 9/30/2023 | 922 | 97 | 36 | 41 | N/A |
| 6/30/2023 | 897 | 96 | 104 | 110 | N/A |
| 3/31/2023 | 962 | 87 | 104 | 108 | N/A |
| 1/1/2023 | 1,045 | 83 | 76 | 81 | N/A |
| 9/30/2022 | 1,113 | 83 | 57 | 62 | N/A |
| 6/30/2022 | 1,097 | 84 | -14 | -10 | N/A |
| 3/31/2022 | 964 | 87 | -15 | -11 | N/A |
| 1/1/2022 | 863 | 82 | -17 | -14 | N/A |
| 12/31/2020 | 591 | 65 | 55 | 60 | N/A |
| 12/31/2019 | 518 | 54 | 27 | 29 | N/A |
| 12/31/2018 | 467 | 41 | 69 | 73 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301319's forecast earnings growth (28.3% per year) is above the savings rate (2.8%).
Earnings vs Market: 301319's earnings (28.3% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 301319's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 301319's revenue (17.7% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 301319's revenue (17.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 301319's Return on Equity is forecast to be low in 3 years time (12.9%).